Medical Properties Trust (MPW)
(Delayed Data from NYSE)
$4.51 USD
-0.05 (-1.10%)
Updated Apr 26, 2024 04:00 PM ET
After-Market: $4.51 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
B Value F Growth F Momentum D VGM
Income Statements
Fiscal Year end for Medical Properties Trust, Inc falls in the month of December .
All items in Millions except EPS data.
12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 | |
---|---|---|---|---|---|
Sales | 872 | 1,543 | 1,545 | 1,249 | 854 |
Cost Of Goods | 42 | 46 | 39 | 25 | 24 |
Gross Profit | 830 | 1,497 | 1,506 | 1,224 | 830 |
Selling & Adminstrative & Depr. & Amort Expenses | 1,160 | 853 | 834 | 725 | 508 |
Income After Depreciation & Amortization | -330 | 645 | 671 | 500 | 323 |
Non-Operating Income | -357 | 315 | 60 | -36 | 51 |
Interest Expense | 0 | 0 | 0 | 0 | 0 |
Pretax Income | -687 | 960 | 731 | 463 | 374 |
Income Taxes | -131 | 56 | 74 | 31 | -3 |
Minority Interest | 0 | 1 | 1 | 1 | 2 |
Investment Gains/Losses | 0 | 0 | 0 | 0 | 0 |
Other Income/Charges | 0 | 0 | 0 | 0 | 0 |
Income From Cont. Operations | -556 | 904 | 657 | 432 | 376 |
Extras & Discontinued Operations | 0 | 0 | 0 | 0 | 0 |
Net Income (GAAP) | -556 | 903 | 656 | 431 | 375 |
Depreciation Footnote | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | 302 | 1,007 | 1,022 | 789 | 488 |
Depreciation & Amortization (Cash Flow) | 632 | 363 | 351 | 289 | 165 |
Income After Depreciation & Amortization | -330 | 645 | 671 | 500 | 323 |
Earnings Per Share Data | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Average Shares | 598.52 | 598.84 | 590.14 | 530.46 | 428.30 |
Diluted EPS Before Non-Recurring Items | -0.93 | 1.50 | 1.11 | 0.81 | 0.87 |
Diluted Net EPS (GAAP) | -0.93 | 1.50 | 1.11 | 0.81 | 0.87 |
Fiscal Year end for Medical Properties Trust, Inc falls in the month of December .
All items in Millions except EPS data.
3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | 3/31/23 | |
---|---|---|---|---|---|
Sales | NA | -122.38 | 306.58 | 337.40 | 350.21 |
Cost Of Goods | NA | 3.30 | 6.48 | 24.68 | 7.11 |
Gross Profit | NA | -125.68 | 300.09 | 312.72 | 343.10 |
SG&A, R&D, and Dept/Amort Expenses | 0.00 | 209.78 | 222.62 | 504.47 | 223.24 |
Income After SG&A, R&D, and Dept/Amort Expenses | 0.00 | -335.46 | 77.47 | -191.75 | 119.86 |
Non-Operating Income | NA | -324.14 | 49.48 | 1.06 | -83.29 |
Interest Expense | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Pretax Income | NA | -659.60 | 126.95 | -190.70 | 36.57 |
Income Taxes | NA | 3.98 | 10.06 | -148.26 | 3.54 |
Minority Interest | NA | 0.36 | 0.19 | -0.40 | 0.24 |
Investment Gains/Losses | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Income/Charges | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Income From Cont. Operations | NA | -663.58 | 116.90 | -42.43 | 33.03 |
Extras & Discontinued Operations | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income (GAAP) | NA | -663.94 | 116.71 | -42.04 | 32.79 |
Earnings Per Share Data | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | 3/31/23 |
---|---|---|---|---|---|
Average Shares | NA | 598.98 | 598.55 | 598.34 | 598.31 |
Diluted EPS Before Non-Recurring Items | NA | -1.11 | 0.19 | -0.07 | 0.05 |
Diluted Net EPS (GAAP) | NA | -1.10 | 0.19 | -0.07 | 0.05 |